Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism CDK5 inhibitors(Cyclin-dependent kinase 5 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Goldfinch Bio, Inc.Startup |
Active Organization Goldfinch Bio, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H23F4N5O |
InChIKeyGHNYLVIESIGHDJ-OAQYLSRUSA-N |
CAS Registry2775311-17-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Polycystic Kidney, Autosomal Dominant | Preclinical | US | Goldfinch Bio, Inc.Startup | 24 Feb 2022 |